Aligos Therapeutics Inc Working Capital to Net Assets Ratio
Aligos Therapeutics Inc working capital to net assets ratio. Aligos Therapeutics Inc (ALGS) has a Working Capital to Net Assets ratio of 114.2% as of March 2026. Working capital of $36.31 Million (current assets of $59.63 Million minus current liabilities of $23.32 Million) is measured against net assets of $31.79 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Aligos Therapeutics Inc (ALGS) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Aligos Therapeutics Inc (2018–2025)
Working capital to net assets ratio of Aligos Therapeutics Inc from 2018 to 2025. This chart shows how Aligos Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 114.2%, reflecting working capital of $36.31 Million against net assets of $31.79 Million USD. See Aligos Therapeutics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Aligos Therapeutics Inc Working Capital to Net Assets Ratio by Year (2018–2025)
Aligos Therapeutics Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Aligos Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ALGS current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 115.1% | $61.63 Million | $53.55 Million | $82.86 Million | $21.23 Million | ▲ +254.6 pp |
| 2024 | -139.5% | $40.40 Million | $-28.97 Million | $62.14 Million | $21.74 Million | ▼ -266.7 pp |
| 2023 | 127.3% | $117.18 Million | $92.08 Million | $141.08 Million | $23.91 Million | ▲ +30.6 pp |
| 2022 | 96.6% | $100.42 Million | $103.90 Million | $133.54 Million | $33.13 Million | ▲ +7.1 pp |
| 2021 | 89.6% | $165.47 Million | $184.73 Million | $204.42 Million | $38.96 Million | ▼ -10.3 pp |
| 2020 | 99.9% | $219.74 Million | $220.04 Million | $250.02 Million | $30.27 Million | ▲ +263.8 pp |
| 2019 | -164.0% | $106.41 Million | $-64.89 Million | $120.23 Million | $13.82 Million | ▲ +453.4 pp |
| 2018 | -617.4% | $84.88 Million | $-13.75 Million | $92.37 Million | $7.49 Million | — |